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Abstract
Background: Low levels of physical activity are common in patients with chronic obstructive pulmonary disease
(COPD), and a sedentary lifestyle is associated with poor outcomes including increased mortality, frequent
hospitalizations, and poor health-related quality of life. Internet-mediated physical activity interventions may
increase physical activity and improve health outcomes in persons with COPD.
Methods/Design: This manuscript describes the design and rationale of a randomized controlled trial that tests the
effectiveness of Taking Healthy Steps, an Internet-mediated walking program for Veterans with COPD. Taking
Healthy Steps includes an uploading pedometer, a website, and an online community. Eligible and consented
patients wear a pedometer to obtain one week of baseline data and then are randomized on a 2:1 ratio to Taking
Healthy Steps or to a wait list control. The intervention arm receives iterative step-count feedback; individualized
step-count goals, motivational and informational messages, and access to an online community. Wait list controls
are notified that they are enrolled, but that their intervention will start in one year; however, they keep the
pedometer and have access to a static webpage.
Discussion: Participants include 239 Veterans (mean age 66.7 years, 93.7% male) with 155 randomized to Taking
Healthy Steps and 84 to the wait list control arm; rural-living (45.2%); ever-smokers (93.3%); and current smokers
(25.1%). Baseline mean St. George’s Respiratory Questionnaire Total Score was 46.0; 30.5% reported severe dyspnea;
and the average number of comorbid conditions was 4.9. Mean baseline daily step counts was 3497 (+/− 2220).
Veterans with COPD can be recruited to participate in an online walking program. We successfully recruited a
cohort of older Veterans with a significant level of disability including Veterans who live in rural areas using a
remote national recruitment strategy.
Trial registration: Clinical Trials.gov NCT01102777
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Background
Burden and management of COPD
Chronic Obstructive Pulmonary Disease (COPD) is a
significant problem worldwide, affecting 9-10% of the
population 40 years of age or older [1,2]. In the U.S.,
COPD is currently the third cause of mortality [3] and
affects 5.1% of the population. Among Veterans the
prevalence is 8.2% [4] with those afflicted by the disease
accumulating more emergency room and outpatient
visits to physicians when compared to persons without
COPD. COPD is characterized by acute exacerbations
(AECOPD), which are responsible for 70% of the total
cost generated by the disease. AECOPD accelerate the
rate of decline of lung function [5] and negatively impact
health-related quality of life (HRQL); nearly 50% of the
patients will continue to need help with their activities
of daily living six months after hospital discharge for an
AECOPD [6]. AECOPD are part of a downward spiral in
functionality and HRQL and are also the main risk fac-
tor for new or recurrent exacerbations [7].
The principles of COPD management include control
of symptoms, prevention of AECOPD, and improving
HRQL. Strategies include smoking cessation, pharmaco-
logical therapy with short- and long-acting bronchodila-
tors and anti-inflammatory inhaled medications, oxygen
supplementation, and early recognition of symptoms. Al-
most all available therapeutic options have been proven
to reduce symptoms, decrease the frequency of exacer-
bations, and improve HRQL [8-11], but none of the
available pharmacologic interventions modifies the pro-
gressive loss of pulmonary function [12]. The recogni-
tion of a high frequency of cardiovascular disease as
cause of death in COPD patients [13] and the role of co-
morbid conditions as risk factors for recurrent exacerba-
tions has strengthened the interest in the management
of other coexistent conditions as an alternative to improve
the prognosis of patients with COPD [14], or to develop
COPD self-management programs [15]. Engagement in
physical activity is a cornerstone of self-management pro-
grams to improve health status.
Exercise and physical activity in COPD
Persons with COPD have significant reductions in phys-
ical activity compared to controls [16,17]. Comorbidities
of cardiovascular disease, musculoskeletal disease, osteo-
porosis [18], loss of skeletal muscle mass [19], muscle
weakness, and weight loss [20] contribute to loss of
functional capacity. Epidemiological and cross-sectional
data have shown that physical activity is related to out-
comes in COPD. Those who have higher levels of phys-
ical activity have a lower risk of hospital readmissions,
acute exacerbations, and COPD-related hospitalizations
[21]. Physical activity levels are the strongest predictor
of mortality, independent of lung function [22].
This association between physical activity and COPD
outcomes may be mediated through improved cardiore-
spiratory fitness or through reduced systemic inflamma-
tion [23]. Despite the benefits of physical activity, few
interventions exist to promote physical activity in persons
with COPD. Pulmonary rehabilitation has been clearly
shown to improve exercise capacity, reduce dyspnea, and
improve HRQL in persons with COPD [24]. Pulmonary
rehabilitation includes exercise training for decondition-
ing, disease management education, management of dys-
pnea, appropriate use of medication, and identification of
depression and other barriers to exercise. Pulmonary re-
habilitation is a potent intervention. The number-needed-
to-treat (NNT) with pulmonary rehabilitation to prevent
one hospital admission is 4 (95% CI 3–8) [25].
Limitations to exercise among COPD patients
Unfortunately, pulmonary rehabilitation programs are typ-
ically hospital based and are not accessible to everyone
who needs them. In addition, the benefits gained after a
typical 12-week supervised program plateau and begin to
diminish after 9–12 months [26]. In a national survey of
COPD patients more than 25% were not aware of the exist-
ence of rehabilitation programs, and an additional 13% re-
ported that pulmonary rehabilitation programs were not
available [27]. Criteria for participation in rehabilitation
programs are usually determined by third party payers, and
insurance could be a factor in receiving the intervention.
Individual barriers identified in some studies include the
need to make changes in the daily routine, competing
needs and duties, and transportation problems [28]. Social
isolation and living in remote areas is common in COPD
patients, with up to 28% of Veterans with COPD residing
in rural and isolated areas [29]. Living in rural or isolated
areas is associated with a lower probability of receiving
home health services and less frequent visits to physicians
[30]. Finally, a systematic review identified lack of support
and program-specific barriers as factors limiting participa-
tion in rehabilitation, while belief in personal benefits and
setting goals are enablers for participation [31]. As a result,
less than 13% of the potential candidates who might benefit
from rehabilitation are referred by their health care pro-
vider [32]. Development of individual, home-based physical
activity programs may address some of the barriers and
may expand the reach to those living far from facilities
that offer formal pulmonary rehabilitation programs. The
Internet and other new forms of information and commu-
nication technology could provide a way to reach this
population. A few studies have demonstrated the feasibility,
acceptability, and efficacy of Internet-mediated smoking
cessation and dyspnea management interventions in COPD
[33,34]. Additionally, we have demonstrated the accuracy of
the Omron HJ-720-ITC in a pilot study of 24 patients with
COPD. At walking speed the pedometer was able to
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capture more than 80% of manual step counts, and the pa-
tients were able to upload the information [35]. In another
study with 90-day follow-up, 27 older Veterans (mean age
72, s.d. 8 years) demonstrated the ability to regularly upload
pedometer step counts to their home computer, and to be
part of a feedback Internet-mediated program. They were
also satisfied with the intervention and would recommend
a similar program to potential participants [36].
Based on the previously reviewed evidence of the ben-
efits of exercise as part of rehabilitation programs and
recognizing the multiple barriers to participation in ex-
ercise programs faced by older patients, we designed the
current pedometer-based, Internet-mediated interven-
tion to promote walking in this population. The long-
term objectives are to develop, test, and disseminate
effective, low-cost interventions that improve HRQL for
Veterans, particularly rural-living Veterans managing
complex chronic conditions, which could be extrapo-
lated to other similar populations.
Methods
Study design
Taking Healthy Steps is a randomized controlled clinical
trial for Veterans with COPD across the U.S. The
coordinating center is located at the VA Center for
Clinical Management Research in Ann Arbor, Michigan.
Conceptual framework
The Taking Healthy Steps intervention is based primarily
on self-regulation theory. The Theory of Self-Regulation
emphasizes an iterative, rational process of behavior
change in which an individual working towards a behav-
ioral goal learns from successes and failures and uses
this knowledge to develop effective behavioral strategies
to achieve his or her goal [37,38] (Figure 1). Accurate
self-monitoring, goal setting, and feedback are critical
components of the cycle of self-regulation. The Taking
Healthy Steps intervention targets the cycle of self-
regulation with four components: 1) step-count feedback
from a pedometer and personal website, 2) automated,
gradually incrementing goals, 3) tailored motivational
messages, and 4) an online community to enhance social
support. Participants upload detailed time-stamped step-
count data. Tailored algorithms based on the data pro-
vide dynamic individualized incremental walking goals
and feedback about success at meeting these goals. Goal
setting is based on Lock and Latham’s demonstration
that high, hard goals improve performance as long as
Figure 1 Conceptual Model for Taking Healthy Steps.
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the goals are not too high [39]. Goal increment is based
on a series of pilot studies in individuals with a variety
of chronic illness [40]. Online communities allow users
to interact with each other by posting messages for
others to read and by reading messages posted by others.
These communities are useful for individuals who report
low baseline social support, which is a predictor of poor
adherence to physical activity interventions.
Study aims
The specific aims of the current clinical trial are:
1. To test the effectiveness of an automated, internet-
mediated walking program on HRQL at four months
and at one year
2. To estimate the effect of the Taking Healthy Steps
program on all cause days of hospitalization over
one year in Veterans with COPD
3. To compare intervention reach, participation, and
satisfaction between rural and urban Veterans
among those randomized to the intervention arm
Identification of target population
The flow of patients through the study is described in
Figure 2. Potential participants are identified from VA na-
tional databases of patients who received care within the
year prior to enrollment from a primary care provider,
cardiologist, or pulmonologist within the VA health
care system. The diagnosis of COPD is based on data
extracted from ICD9 codes of 491.x Chronic Bronchitis,
492.x Emphysema and 496.x Chronic Airway Obstruc-
tion NEC indicating the likely presence of COPD. The
identification of COPD patients using a similar algo-
rithm has been associated with appropriate diagnostic
accuracy (area under the ROC curve 0.75) [41]. Veterans
less than 40 years old (to minimize misclassification with
asthma) and individuals with diagnosis codes for quadri-
plegia and paraplegia, wheelchair dependence, dementia,
or pregnancy-related diagnoses or procedures within the
previous year were not eligible. We also excluded Veterans
from VISN 01 facilities, where another COPD study using
the Taking Healthy Steps platform was actively recruiting
participants. After identifying potential participants, their
Figure 2 CONSORT diagram of the enrollment and allocation in the Taking Healthy Steps clinical trial.
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zip codes were matched to Rural Urban Commuting
Codes (RUCA), a validated algorithm developed by the
U.S. Department of Agriculture – Economic Research
Service to classify U.S. census tracts using measures of
population density, urbanization, and daily commuting
[42], which identified potential participants as living in
urban or rural areas.
Based on reported response rates of 2-5% in similar
surveys of COPD patients, a random subset of 30,000
Veterans (half urban and half rural) was selected from
the pool to receive mailed invitations to participate in
the program. The invitation letter includes a brief de-
scription of the study and key eligibility criteria, as well
as a website address to visit for more information, a six-
digit numeric ID code to enter into the online form that
allows them to proceed with further eligibility screening,
and a pamphlet about research within the VA system.
This remote recruitment strategy was intentionally de-
signed to expand the reach to rural Veterans. Letter recip-
ients who visit the website read an expanded description
of the study. If interested, they enter their email address
into a web form and complete an online screening ques-
tionnaire that assesses their demographics, health status,
physical activity level, and computer access.
Eligibility
Eligibility requirements include: Veteran; age ≥ 40 years
old; diagnosis of COPD, emphysema, or chronic bron-
chitis based on administrative ICD-9 codes or self-
report; able to walk a minimum of one block; sedentary
(defined by < 150 minutes of self-reported physical activ-
ity per week); have a doctor or primary care provider
who can give medical clearance; competent to give in-
formed consent, and not having a legal guardian; regular
email user (checking weekly); have access to a computer
with an Internet connection, a USB port, and Windows
XP, Vista, 7, or 8; not involved in another pedometer-
based walking program.
Upon submission of the eligibility survey responses, an
algorithm determines eligibility in real time. The website
then directs eligible individuals to an online consent
form with a click-through agreement and the opportun-
ity to have study staff contact them to answer questions.
Eligible participants present a medical clearance form to
their health care provider to receive confirmation that
the walking program is safe for them, and the signed
form is faxed back to the coordinating center. A similar
procedure of medical clearance has been previously
tested in other studies by our group [43].
Baseline measures and randomization
After completing the online screening and informed
consent, participants complete online surveys about the
primary outcome of HRQL using the St. George’s
Respiratory Questionnaire and the general health status
question from the SF-36. The surveys also assess demo-
graphics; health history including comorbidities and
COPD hospitalizations; motivations and barriers for
walking; knowledge and attitudes about COPD, current
cigarette smoking, current supplemental oxygen use, the
Modified Medical Research Council (MMRC) dyspnea
score, depression, social support; and comfort with com-
puters. Once the baseline survey is complete, study staff
mail participants an Omron pedometer (HJ-720 ITC)
with a USB upload cable and instructions about upload-
ing pedometer data and pedometer care and use. This
pedometer has been previously validated in a similar
population [44]. Participants are asked to wear their pe-
dometers throughout the day for seven days to assess
their baseline step counts. Pedometers have a sticker
over the display during the baseline assessment period,
and no step-count goals or feedback are provided dur-
ing this stage. At the end of the seven days the partici-
pant uploads their pedometer data using the USB cable
and their computer. Immediately after completion of
baseline pedometer data collection and receipt of the
medical clearance, the participants are automatically
randomized to one of two arms: 1) Internet-mediated,
pedometer-enhanced program (Taking Healthy Steps)
or 2) Wait list control. Randomization is stratified by
breathlessness (defined by MMRC) and urban vs. rural
residence.
Pedometer-based, internet-mediated intervention
(Taking Healthy Steps)
After being randomized to Taking Healthy Steps, partici-
pants receive an automated email message informing
them of their first step-count goal and instructing them
to remove the sticker from their pedometer. They also
gain full access to their personal home page with individu-
alized step-count goals, step-count feedback, graphs, and
motivational messages. Participants receive two kinds of
tailored messages on the website: a weekly motivational
and an every-other-day informational message. The weekly
motivational messages are based on individual responses
to the baseline survey and address specific characteris-
tics such as oxygen use and cigarette smoking, motiva-
tions, and barriers reported by the individual participant,
highlighting benefits of exercise while addressing per-
ceived personal barriers and strategies to overcome those
barriers. A new informational message appears on the
study home page every other day; some of these messages
contain disease-specific content related to COPD while
others are generic information about walking and health.
Disease-specific content includes education about the
potential benefits of walking for persons with COPD
and overcoming COPD-specific barriers to walking (fear
of becoming short of breath, fear of running out of oxygen
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in a public place, embarrassment with use of oxygen tank
in public places). In addition, information is provided on
specific problems (use inhaler before starting out on a
walk), anticipated problems (walk an unknown course
with a spouse first, walking on different surfaces and dur-
ing different seasons), and building confidence in partici-
pating in a regular walking program (walk a specific route
that you know you can complete without becoming short
of breath). Where possible, content is evidence-based and
modeled on content used in previously published COPD
self-management and pulmonary rehabilitation studies.
An example of the messages is displayed in Figure 3. Both
the motivational and informational messages address bar-
riers to walking that we have identified as being significant
to COPD patients in a similar trial [45].
Participants are asked to wear the pedometer every
day, from waking to sleeping, during the initial 16-week
period of intervention, and are encouraged to continue
wearing and uploading the data throughout the eight-
month maintenance phase.
Feedback is provided in three ways: 1) participants can
read their step-count data from the pedometer display
throughout the day; after uploading step-count data to
the website, they can select from a variety of detailed
graphs displaying different views of their step counts, in-
cluding weekly and daily views with daily or hourly step-
count totals; 2) participants can look back at their
graphs and goals from previous weeks; and 3) the web-
site displays a textual message about their step-count
average for the week.
Goal-setting is provided each week for the entire one-
year intervention period, with participants receiving a
new individually tailored and automatically calculated
daily step-count goal. The algorithm for calculating step-
count goals was developed based on a series of usability
studies, pilot studies, and RCTs in participants with type
2 diabetes, coronary artery disease, and obesity [40,46].
This algorithm has been validated for use in similar
populations [43]. The algorithm involves adding a fixed
increment to the average step counts of uploaded ped-
ometer data for the participant over the previous seven
days. Because COPD patients tend to be less physically
active and may find it more challenging to increase
their step counts, the goal is never higher than a 600-
step increment, rather than the 800- or 1200-step in-
crements reported for other populations. Goals are
Figure 3 Example of the informational messages provided for participants in Taking Healthy Steps.
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rounded off to the nearest 100 steps, and the maximum
possible goal is 10,000 steps per day. Each Sunday, the
goal calculation algorithm is run and sends participants
automated emails with their personalized daily step-
count goal for the week, which appears in the step-
count feedback section on the website, both in text
form and graphs. Goals are not necessarily monotonic-
ally increasing. For example, if a participant is sick, and
thus records low step counts for one week, the subse-
quent week’s goal might be lower than the goal for the
week the participant was sick. A snapshot of the indi-
vidual step-count webpage can be seen in Figure 4.
Additionally, all participants randomized to the inter-
vention arm have access to online community features.
They are able to read and post messages on the commu-
nity message board under three different sections: Help
Desk, Meet and Greet, and Sidewalk Talk. Study staff
moderate and seed the message board. They also re-
spond to some posts directly and stage competitions to
encourage posting. The use of online communities has
previously increased program retention in similar studies
[47]. Finally, all participants who are randomized to the
intervention arm have access to the study staff for ques-
tions, which could be initiated by sending an email or
directly on the website through a form. Participants can
also call the staff on a toll-free number. A screenshot of
the online communities is presented in Figure 5.
Wait list (control arm)
Wait list controls are notified that they are enrolled in
the study, but that they will not be able to start the ac-
tive intervention for one year. They are neither assigned
step-count goals nor do they have access to the person-
alized dynamic website during the year long waiting
period. However, they have access to a brief static web-
page that provides a checklist of completed surveys and
their week number in the study. Participants keep the
study pedometer and are asked to log in monthly to re-
port adverse events and to upload their pedometer data,
with no other incentive to log into the website and no
feedback of pedometer data or goal setting. They are
given no specific instructions on exercise.
Outcomes and data collection procedures
The primary outcome is change in Saint George’s Respiratory
Questionnaire (SGRQ) Total Score at 4 and 12 months
compared to baseline. The SGRQ is a well validated
disease-specific HRQL measure [48] widely used in
Figure 4 Example of the step-counts screen for participants in Taking Healthy Steps.
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clinical trials of pulmonary rehabilitation, disease man-
agement interventions, and exercise [49] in patients
with COPD. SGRQ will be measured at baseline, four
months, and one year after randomization.
Hospitalizations for AECOPD, self-reported dyspnea,
and change in average daily step counts will be secondary
outcomes. To ascertain hospital admissions, a two-way
process will be performed, using both self-reported hospi-
talizations (which capture non-VA admissions) and identi-
fying hospital admissions through the VA administrative
databases. ICD-9 codes will be used to identify cause of
admission. AECOPD will be defined by a previously vali-
dated combination of inpatient and outpatient ICD-9
codes [50], and validated algorithms will also be used to
identify pneumonias and episodes of respiratory failure
[51,52]. Dyspnea is measured with the MMRC Dyspnea
Score [53,54]. Change in average daily step counts will
be calculated using 7 days where at least 5 of the 7 days
have at least 100 steps and 8 hours of activity. Goal
commitment (percentage of intervention days during
which step-count goals are achieved, as well as self-
reported goal commitment and perceived difficulty of
goal level evaluated by the Likert scale and open-ended
questions) and participant retention are also secondary
outcomes. Endpoints are evaluated at baseline, four
months, and one year after randomization.
Power analysis and sample size
The sample size is calculated based on a between-arm
comparison of the primary outcome – change in SGRQ
total score over four months – and to allow for a com-
parison between rural vs. urban Veterans within the
intervention group. In order to have adequate power for
the comparison between rural vs. urban Veterans within
intervention group, randomization is done in a 2:1 pro-
portion to the intervention arm. We made the following
assumptions, all of which are supported by the literature.
First, as the minimal clinically significant mean change
is SGRQ of 4 units [55], we assume at least a 4-point
drop in SGRQ in the intervention arm, a conservative
estimate of what might be expected with pulmonary re-
habilitation or physical activity interventions in patients
with COPD [56,57]. In contrast, wait list controls are ex-
pected to experience some deterioration in SGRQ even
over a short period of time. In one study of 624 patients
with COPD, SGRQ steadily worsened over time with an in-
crease of approximately 2 units per year. The reported
standard deviation of the change in SGRQ is approximately
Figure 5 Example of the online communities and forums for participants in Taking Healthy Steps.
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10 for the intervention and wait list control groups over
four-months. Thus to detect with 80% power a conserva-
tively estimated between-arm difference in mean change of
4.3 units using a two-tailed 0.05-level test based on regres-
sion analysis and assuming a 2:1 ratio of enrollment, we es-
timated that 192 evaluable participants would be needed in
total, with 128 randomized to the intervention arm and 64
to the control arm. The proposed sample size would pro-
vide 80% power to detect a difference within intervention
arm between rural vs. urban Veterans of 5 units or larger
assuming a standard deviation of 10. Assuming a 20%
dropout rate, a total of about 240 participants will be
recruited.
Monitoring and reporting of adverse events
Participants can report an adverse event (AE) by phone,
website, or email, and are invited to do so every 30 days.
The AEs are tracked electronically in a participant man-
agement system and classified as serious if they require
hospitalization or result in significant disability or classi-
fied as minor if they result in minimal or no disability
and do not require hospitalization.
Ethical and additional safety provisions
Ethical approval for this study was granted by the VA
Ann Arbor Healthcare System Human Studies Sub-
committee. Additionally, unsupervised home-based exer-
cise programs in the chronically ill elderly require the
design of safety provisions to maximize the positive im-
pact, while decreasing the chances of adverse events.
The current clinical trial includes preventative measures
to increase safety, such as pre-inclusion evaluation and
clearance by the personal physician, educational content
on the website about the proper shoes and socks to
wear, and weather-related recommendations. In order
to prevent inappropriate or offensive interactions on-
line, all community posts are reviewed for content within
48 hours and removed if the research staff considers the
post offensive or hostile or to protect personally identify-
ing health information. Participants can also report con-
cerns about other participant’s posts to the study staff.
Analysis plan
Descriptive statistics including proportions or means
and their standard deviations are used, when appropri-
ate, to describe various participant characteristics by
study groups, such as demographics, symptoms, place of
residency (rural vs. urban), and SGRQ scores at baseline
(randomization) as well as outcome variables including
changes in SGRQ total scores at 4 months and one year.
The primary aim is to compare HRQL at four months
and at one year in the intervention group compared to
the wait list control group whose exposure to the inter-
vention is delayed. Analyses will use the intent-to-treat
approach in which the person is considered to be in his/
her randomly assigned condition no matter how much
he/she participates in it. Separate regression analysis will
be done using changes in SGRQ from baseline to four
months as the response variable and also using changes
from baseline to one year as the response variable. Each
regression model will include as primary predictor an in-
dicator for the intervention group and will be adjusted
for the baseline values of the response variable and the
balancing factors of breathlessness and place of resi-
dence. The SGRQ is normally distributed in the COPD
population and has true interval scale properties, and
thus it is appropriate as a response variable in regression
analyses [58]. Additionally, baseline characteristics in-
cluding age, sex, COPD severity, baseline step counts,
and current smoking status will be tested for any imbal-
ances between study groups and/or for potential con-
founding and will be included in the regression model as
appropriate to adjust for confounding.
For the secondary outcome of number of days of
hospitalization during the year following randomization,
we will use a Poisson regression or a negative binomial
regression to make the between-group comparison, with
days of hospitalization as the outcome variable, number
of follow-up days as the offset variable, and an indicator
for the intervention arm as the primary predictor. The
model will be adjusted for breathlessness, place of resi-
dence and potential confounders, including age, sex, and
COPD severity. Additional secondary analyses will exam-
ine ER visits, days of hospitalization for COPD-specific
diagnoses, ICU days, and total number of admissions
using the same methods.
Results
Baseline characteristics of participants
Mailed recruitment materials were sent to 28,957 Veterans
identified from the administrative database, and 779
provided response and were screened for eligibility
(response rate of 2.7%). The most common reason for
ineligibility was self-reported moderate physical activity
greater than 150 minutes a week. After receiving con-
sent from 307 participants, 239 were randomized: 155
to the intervention and 84 to the wait list control. The
recruitment of patients and reasons for exclusion are in
the Consort diagram (Figure 2). The demographic, clin-
ical characteristics, baseline step counts, and HRQL
measurements are described in Table 1. There was no sig-
nificant difference in baseline characteristics between the
two arms. In general, participants are older (mean age
66.7 ± 8.8); predominantly male (93.7%); self-described as
retirees (58.2%) or not currently working (24.7%); and al-
most half live in rural or remote areas (45.2%); and 25.1%
currently smoke. The clinical characteristics include a
high number of comorbidities (mean 4.9 per patient),
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Table 1 Baseline characteristics of the participants in taking healthy steps
Intervention group (n = 155) Control group (n = 84) Total (n = 239) p-value
Demographics
Age in years (mean [s.d.]) 66.9 (8.7) 66.4 (9.2) 66.7 (8.8) 0.71
Male gender (n [%]) 147 (94.8) 77 (91.7) 224 (93.7) 0.33
Race/Ethnicity (n [%]) 0.88
Black 7 (4.5) 3 (3.6) 10 (4.2)
White 143 (92.3) 79 (94.0) 222 (92.9)
Other/combined 5 (3.3) 2 (2.4) 7 (2.9)
Hispanic 5 (3.3) 1 (1.2) 6 (2.5) 0.34
Socioeconomics
Community setting (n [%]) 0.79
Urban 84 (54.2) 47 (56.0) 131 (54.8)
Rural 71 (45.8) 37 (44.1) 108 (45.2)
Employment (n [%]) 0.79
Retired 94 (60.7) 45 (53.6) 139 (58.2)
Full-Time 14 (9.0) 7 (8.3) 21 (8.8)
Part-Time 10 (6.5) 6 (7.1) 16 (6.7)
Ill, disabled or unemployed 35 (22.6) 24 (28.5) 59 (28.6)
Other 2 (1.3) 2 (2.4) 4 (1.7)
Education (n [%]) 0.29
Below high school 4 (2.6) 2 (2.4) 6 (2.5)
High school or GED 34 (22.2) 11 (13.3) 45 (19.1)
Vocational/Technical 25 (16.3) 11 (13.3) 36 (15.3)
Some college 52 (34.0) 29 (34.9) 81 (34.3)
College graduate 38 (24.8) 30 (36.1) 68 (28.8)
Annual income (n [%]) 0.34
Below $30 k 66 (42.6) 35 (41.7) 101 (42.3)
$30 to < $40 k 23 (14.8) 14 (16.7) 37 (15.5)
$40 to < $50 k 21 (13.6) 5 (6.0) 26 (10.9)
> $50 k 24 (15.5) 19 (22.6) 43 (18.0)
No answer 21 (13.6) 11 (13.1) 32 (13.4)
Clinical characteristics
Ever-smokers (n [%]) 146 (94.2) 77 (91.7) 223 (93.3) 0.48
Current smokers (n [%]) 42 (27.1) 18 (21.4) 60 (25.1) 0.34
Oxygen use (n [%]) 35 (22.6) 21 (25.0) 56 (23.4) 0.67
General health (n [%]) 0.49
Excellent, very good 9 (5.8) 9 (10.7) 18 (7.5)
Good 49 (31.6) 26 (31.0) 75 (31.4)
Fair or poor 96 (61.9) 49 (58.3) 145 (60.7)
No answer 1 (0.7) 0 (0.0) 1 (0.4)
SGRQ score (mean [s.d.])
Total score 45.5 (15.4) 46.8 (15.6) 46.0 (15.4) 0.54
Symptoms score 56.9 (19.4) 56.0 (19.9) 56.6 (19.5) 0.72
Activity score 62.1 (20.3) 64.2 (18.0) 62.8 (19.5) 0.44
Impact score 32.2 (16.4) 34.1 (17.9) 32.9 (16.9) 0.41
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moderate to severe dyspnea in 30.5%, and a total SGRQ
score of 46.0 ± 15.4 points. The average baseline daily step
counts is 3,497 ± 2,220 steps.
Discussion
Patients with COPD experience progressive deterior-
ation in their functional status, HRQL, and ability to ex-
ercise. Although continuous exposure to tobacco and
poor lung function are strong factors related to poor
outcomes in this population, the presence of comorbidi-
ties has emerged as a significant factor associated with
all unfavorable COPD outcomes. Lack of physical activ-
ity is both a consequence and a mediator of COPD out-
comes, and the success of pulmonary rehabilitation in
decreasing hospital admissions, improving HRQL, and
decreasing dyspnea has made rehabilitation one of the
cornerstones of COPD management. Unfortunately, many
barriers limit initial participation in rehabilitation, and
there is a need for reinforcement to maintain the gains
achieved by patients after completion of a formal program.
Veterans with COPD face these barriers, which are com-
plicated by the high frequency of rural residency, comor-
bidity, and unemployment in this population. Building on
previous research that has shown the feasibility of using a
pedometer by COPD patients, the accuracy of the device,
the ability to individualize and have feedback of an auto-
mated intervention, and patients’ favorable views towards
participating in online communities, we designed the
current pedometer-enhanced, Internet-mediated clinical
trial of physical activity for Veterans with COPD. The
clinical trial includes unique characteristics such as identi-
fication of the pool of potential participants using admin-
istrative databases, remote orientation on the use of the
pedometer, patient-initiated acquisition of medical clear-
ance for participation, automated web-based data collec-
tion, use of multiple communication tools (e.g. pedometer,
participation in online communities), and a dynamic,
adaptive algorithm for step-count goals.
Our baseline (enrollment) data suggest that by using
remote communication tools it is feasible to recruit
often hard-to-reach individuals, including: rural and re-
mote residents; elderly subjects; the unemployed; and
those with multiple comorbidities [59]. Follow-up at four
months and one year are required to evaluate the primary
and secondary outcomes (HRQL, step counts, dyspnea,
exacerbations and hospitalizations), and the retention and
satisfaction with the program. Taking Healthy Steps will
also be implemented after one year for wait list controls.
Potential limitations of the current design include the low
response to the mailed invitation, but this is no different
from other studies of investigator-initiated mail contact
with COPD patients [27], and the absence of spirometry
for confirmation of COPD. In addition, the findings may
not be generalizable to women and other patients with
COPD who have Internet access but choose not to partici-
pate. Participants need some degree of familiarity with the
use of computers and information technology, but as the
penetration of the Internet within the chronically ill has
increased [60], the potential use of the program could in-
crease. Despite these limitations, this study will provide
additional answers and insights to further develop, refine,
test, and disseminate effective, low-cost behavioral inter-
ventions that improve HRQL in the older patients with
multiple comorbidities who live in remote areas.
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